Combined Activity and Cognitive Intervention for ICU Survivors
Launched by THE UNIVERSITY OF HONG KONG · Oct 31, 2023
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
With the growing cohort of patients surviving after ICU treatment, the long-term consequences of critical illness have gained increased attention in the past decade. It is common for ICU survivors to experience long-term impairments in one or more domains of physical, cognitive or psychological functioning that persist beyond acute care hospitalization for a critical illness, impairments that are collectively known as post-intensive care syndrome (PICS).
As PICS is a relatively new syndrome, research is accumulating on different approaches to tackling it. There are several limitations on p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Chinese adults aged ≥18
- • 2. has been admitted to ICU for at least 4 days
- • 3. discharged home
- • 4. able to perform basic activities of daily living before ICU admission
- • 5. living with family
- • 6. has an electronic device that can access the internet (patient/family)
- • 7. able to walk for at least 10 metres (assisted or unassisted)
- Exclusion Criteria:
- • 1. cannot read Chinese
- • 2. has musculoskeletal injury precluding exercise training
- • 3. is receiving structured out-patient pulmonary or cardiac rehabilitation after discharge
- • 4. has clinically evident dementia or significant impairment from an acute brain problem (e.g. traumatic brain injury, stroke, subarachnoid haemorrhage or hypoxic brain injury) that precludes following the study protocol
- • 5. has prolonged length of stay (≥28 days) in the step-down wards
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Polly Li, Dr
Principal Investigator
The University of Hong Kong, School of Nursing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported